| EQA 2027 - Anti-PF4 antibody testing (TIH) |
|---|
|
Expert Biologists - Program Coordinators:
Béatrice GUILLEMIN EQA performed since 2022
Number of analytical sites registered in 2026: 103 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program evaluates the accuracy of different assays for detecting anti-PF4 antibodies in the diagnosis of heparin-induced thrombocytopenia.
Statistical reports are sent with supporting comments from the expert clinical biologists / program coordinators.
This program is only intended for immunological methods:
|
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
3 – List of analytes assessed
Results are evaluated both quantitatively (in U/mL and OD) and qualitatively (negative, positive or equivocal).
4 – Description of the control samples
Liquid human control plasma (citrate) (ready-to-use 0.5 mL samples), spiked with anti-PF4 monoclonal antibody.
| | Legal notices and privacy policy | General terms of sale | | Last updated: 13 October 2026 | Copyright © 2011-2026 ProBioQual All rights reserved |